deoxyglucose has been researched along with Benign Neoplasms in 153 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 23 (15.03) | 18.7374 |
1990's | 56 (36.60) | 18.2507 |
2000's | 21 (13.73) | 29.6817 |
2010's | 43 (28.10) | 24.3611 |
2020's | 10 (6.54) | 2.80 |
Authors | Studies |
---|---|
Aissa, AF; Bhaskar, P; Blaha, CS; Brooks Robey, R; Frolov, MV; Hay, N; Jeon, SM; Kang, S; Nogueira, V; Patra, KC; Ramakrishnan, G; Rho, H; Terry, AR | 1 |
Bhansali, MP; Bhansali, PR; Borkar, MR; Chaturbhuj, GU; Muntean, BS; Viola, RE; Wijayasinghe, YS | 1 |
Chatterjee, S; Dash, SK; Dey, S; Giri, B; Haldar, S; Manna, R; Mondal, T; Murmu, N; Saha, I; Sarkar, TR | 1 |
Ratajczak, K; Stobiecka, M | 1 |
Gomori, JM; Harris, T; Katz-Brull, R; Nardi-Schreiber, A; Sapir, G; Sosna, J; Uppala, S | 1 |
Huang, H; Li, S; Liu, Y; Luo, Z; Ma, W; Pardeshi, A; Sun, J; Wan, Z; Xu, J; Zhang, Z | 1 |
Kumanogoh, A; Okamoto, Y; Sasawatari, S; Toyofuku, T | 1 |
Ahmad, S; Farooqui, A; Husain, A; Khanam, A; Rehman, S; Yusuf, MA | 1 |
Chevet, E; Eldering, E; Favaro, F; Iurlaro, R; Lucendo, E; Majem, B; Marchetti, S; Muñoz-Pinedo, C; Nadal, E; Püschel, F; Redondo-Pedraza, J; Ricci, JE | 1 |
Fujikawa, R; Ito, C; Kira, S; Misumi, M | 1 |
Lampidis, TJ; Mesri, EA | 1 |
Du, W; Fan, Y; Liu, J; Sun, C; Wang, B; Wang, J; Wu, T; Xie, W; Yang, H; Yao, Z | 1 |
Baleja, JD; Degterev, A; Dutta, I; Jhaveri, A; Pattni, BS; Torchilin, V | 1 |
Chung, SK; Chung, SS; Yung, KK; Zhang, SQ | 1 |
Mathews, EH; Mathews, GE; Meyer, AA | 1 |
Branca, JA; Chow, KH; Costa, M; Hasham, MG; Labrie, NJ; Mills, KD; Perkins, BRA; Roopenian, DC; Rosales, C; Sproule, TJ; Stafford, G; Wilson, JJ; Wolf, EE | 1 |
Yamada, K | 1 |
Floberg, JM; Schwarz, JK | 1 |
Binshtock, E; Bookout, AL; Connelly, JP; Fon Tacer, K; Kamiński, MM; Kim, M; Klein, J; Lord, T; Montoya, MC; Oatley, JM; Oatley, MJ; Potts, PR; Pruett-Miller, SM; Ravichandran, R; Tillman, H | 1 |
Glenister, A; Hambley, TW; Simone, MI | 1 |
Chen, Y; Deng, L; Edwards, CK; Huang, C; Lei, Y; Li, J; Li, Y; Liu, R; Liu, Y; Lu, Y; Wei, Y; Yuan, K | 1 |
Axten, JM; Cao, Y; Kumar, R; Kurtoglu, M; Lampidis, TJ; Liu, H; Xi, H | 1 |
Kurtoglu, M; Lampidis, TJ; Xi, H | 1 |
Boisbrun, M; Cerella, C; Diederich, M; Flament, S; Grillier-Vuissoz, I; Kuntz, S; Mazerbourg, S | 1 |
Fukumoto, M; Kunugita, N; Noma, N; Ochiai, Y; Oikawa, T; Sano, Y; Shimura, T | 1 |
Hu, J; Li, J; Sun, Y; Wang, F; Wang, S; Zhang, D | 1 |
Cheng, G; Dwinell, MB; Hardy, M; Joseph, J; Kalyanaraman, B; McAllister, D; Ouari, O; Zielonka, J | 1 |
Hagen, T; Hong, SY | 1 |
Chen, TY; Chuang, JH; Hsu, WM; Huang, CC; Lin, LL; Lin, TK; Liou, CW; Wang, PW; Wang, SY | 1 |
Kobayashi, H; Matsumoto, K; Nishimura, H; Yoshida, M | 1 |
Hirota, K; Perkins, G; Yamaguchi, R | 1 |
Ahmad, S; Ashraf, JM; Aslam Yusuf, M; Choi, I; Lee, EJ; Shahab, U; Tabrez, S | 1 |
Baudy, AR; Daemen, A; Evangelista, M; Gao, M; Haley, B; Hatzivassiliou, G; Pusapati, RV; Sandoval, W; Settleman, J; Wilson, C | 1 |
Barredo, J; Kurtoglu, M; Lampidis, TJ; Leclerc, G; León-Annicchiarico, CL; Liu, H; Liu, X; Merchan, J; Munoz-Pinedo, C | 1 |
Edatt, L; Kiran, MS; Kumar, SV; Kunhiraman, H; Poyyakkara, A; Raveendran, V; Sudhakaran, P; Thekkeveedu, S | 1 |
Choi, EK; Jang, SJ; Jo, SY; Jung, CL; Lee, C; Mun, H; Oh, JH; Suh, YA | 1 |
D'Souza, CJ; Vishwanatha, A | 1 |
Chen, Y; Xiong, QF | 1 |
Kovar, JL; Olive, DM; Sevick-Muraca, E; Simpson, MA; Volcheck, W | 1 |
Kurtoglu, M; Lampidis, TJ | 1 |
Lin, X; Ren, J; Wang, X; Zhang, J | 1 |
Dwarakanath, B; Jain, V | 1 |
Chen, J; Khuri, FR; Liu, T; Liu, X; Sun, SY; Xiong, L; Zhong, D; Zhou, Q; Zhou, W; Zong, Y | 1 |
Dwarakanath, BS | 1 |
Adhikari, JS; Afrin, F; Dwarakanath, BS; Farooque, A | 1 |
Neary, CL; Pastorino, JG | 1 |
Bhardwaj, R; Dwarakanath, BS; Sharma, PK; Varshney, R | 1 |
Gatenby, RA; Silva, AS | 1 |
Aydogan, B; Chaudhary, A; Chmura, SJ; Kurtoglu, M; Li, J; Pelizzari, C; Rajh, T; Wietholt, C | 1 |
Carvalheira, JB; Dias, MM; Osório-Costa, F; Rocha, GZ; Ropelle, ER; Rossato, FA; Saad, MJ; Vercesi, AE | 1 |
Chang, YT; Samanta, A; Vendrell, M; Yun, SW | 1 |
Bertino, JR; DiPaola, RS; Goodin, S; Gounder, MK; Kong, AN; Lin, H; Stein, M | 1 |
Ellisman, M; Janssen, E; Kitada, S; Perkins, G; Reed, JC; Yamaguchi, R | 1 |
Ajani, J; Cheong, JH; Dennison, JB; Hall, H; Ki Hong, W; Kundra, V; Lee, JS; Liang, J; Lu, Y; Mills, GB; Nguyen-Charles, C; Park, ES; Ravoori, M; Tsavachidou, D; Wa Cheng, K; Zhang, D | 1 |
Perkins, G; Yamaguchi, R | 1 |
Choi, Y; Lee, JH | 1 |
Huo, J; Jin, Z; Lin, X; Pang, Y; Ren, J; Wang, X; Zhang, J; Zhang, W; Zhang, Y | 1 |
Bhardwaj, R; Jadon, SP; Sharma, PK; Varshney, R | 1 |
Luo, Z; Nitin, N; Samadzadeh, KM; Tikekar, RV | 1 |
Chiorean, EG; Dipaola, RS; Jung, DT; Kroll, S; Kurtoglu, M; Lampidis, TJ; Langmuir, VK; Papadopoulos, K; Raez, LE; Ricart, AD; Rocha Lima, CM; Rosenblatt, J; Schlesselman, JJ; Stein, MN; Tolba, K | 1 |
Cao, J; Chen, WR; Cui, S; Du, C; Gu, Y; Li, S; Qian, Z; Tian, J; Wan, S; Wang, G | 1 |
HUDSON, MT; WOODWARD, GE | 1 |
HOGG, JF; NIRENBERG, MW | 1 |
BURK, D; LANDAU, BR; LASZLO, J; STENGLE, J | 1 |
BROOKS, JL; CHRISTENSEN, E; STEWART, CJ; WICK, AN | 1 |
COE, EL; IBSEN, KH; McKEE, RW | 1 |
Hiraku, Y; Kawanishi, S; Mizutani, M; Murata, M; Oikawa, S | 1 |
Berridge, MV; Kansara, M | 1 |
Maity, A; Tuttle, SW | 1 |
Fukuda, H; Furumoto, S; Ishiwata, K; Iwata, R; Kawamura, K; Kubota, K | 1 |
Kurtoglu, M; Lampidis, TJ; Maher, JC | 1 |
Carvalheira, JB; de Souza, CT; Faria, MC; Morari, J; Pauli, JR; Ropelle, ER; Saad, MJ; Ueno, M; Velloso, LA; Zecchin, KG | 1 |
Sinkovics, J | 1 |
Gao, N; Kurtoglu, M; Lampidis, TJ; Lane, AN; Lehrman, MA; Maher, JC; Savaraj, N; Shang, J; Wangpaichitr, M | 1 |
Avilés-Salas, A; Carreño-Fuentes, L; Gallardo-Pérez, JC; Maldonado-Lagunas, V; Marín-Hernández, A; Moreno-Sánchez, R; Rodríguez-Enríquez, S | 1 |
Khuri, FR; Liu, X; Marcus, AI; Schafer-Hales, K; Sun, SY; Zhong, D; Zhou, W | 1 |
Gillespie, E; Lichtenstein, LM; Schleimer, RP | 1 |
Carrasquillo, JA; Larson, SM | 1 |
Ahonen, A; Illukka, T; Johansson, R; Kiuru, A; Nordman, E; Paul, R; Roeda, D; Söderström, KO; Solin, O; Talvio, T | 1 |
Fukuda, H; Ido, T; Kiyosawa, M; Matsuzawa, T; Sato, T; Takahashi, T; Watanuki, S; Yoshioka, S | 1 |
Fowler, JS; Som, P | 1 |
Graham, MM; Grunbaum, Z; Harp, GD; Kaplan, HG; Larson, SM; Rasey, JS; Sale, GE; Weiden, PL; Williams, DL | 1 |
Jain, VK; Kalia, VK; Otto, FJ | 1 |
Darcourt, J; Lagrange, JL; Maublant, J | 1 |
Keyes, JW | 1 |
Knapp, WH | 1 |
Oberhausen, E; Schaefer, A | 1 |
Gatenby, RA | 1 |
Delbeke, D; Hendrix, B; Kessler, RM; Martin, WH; Ohana, I; Patton, JA; Sandler, MP; Weinfeld, Z | 1 |
Lawson, MA | 1 |
Ackermann, RJ; Cotton, L; Ficaro, EP; Macfarlane, DJ; Minn, H; Shreve, PD; Wahl, RL | 1 |
Castle, VP; Dole, MG; Hernandez, RJ; Hutchinson, RJ; Koeppe, RA; Mitchell, DS; Prakash, D; Shulkin, BL; Ungar, DR | 1 |
Larson, SM | 1 |
Boland, GW; Dixon, J; Goldberg, MA; Lee, MJ; Mayo-Smith, WW; McNicholas, MM; Mueller, PR | 1 |
Leskinen-Kallio, S | 1 |
Arimizu, N; Imaseki, K; Itami, J; Okada, J; Oonishi, H; Uno, K; Yoshikawa, K | 1 |
Abbott, FD; Drane, WE; Kuperus, JH; Mastin, ST; Nicole, MW | 1 |
Alavi, A; Chandramouli, B; Gupta, NC; Kim, CK | 1 |
Aisen, AM; Cieslak, RD; Koeppe, RA; Meyer, CR; Quint, LE; Wahl, RL | 1 |
Glaspy, JA; Hawkins, R; Hoh, CK; Phelps, ME | 1 |
Alpert, NM; Fischman, AJ | 1 |
Kubota, K; Kubota, R; Yamada, S | 1 |
Delbeke, D; Martin, WH; Patton, JA; Sandler, MP | 1 |
Jones, T; Price, P | 1 |
Wahl, RL; Zasadny, KR | 1 |
Kabelitz, D; Kremer, B; Lode, H; Meinertz, T; Sauerbruch, T; Sterry, W; Strauss, LG | 1 |
Ide, M; Kobayashi, S; Mitomi, T; Shohtsu, A; Suzuki, Y; Takagi, S; Yasuda, S | 1 |
Bender, H; Biersack, HJ; Kozak, B; Reichel, C; Ruhlmann, J; Schomburg, A; Sommer, T | 1 |
Wagner, HN | 2 |
Pauwels, EK; Van Wyngaarden, KE | 1 |
Kubota, K | 1 |
Strauss, LG | 2 |
Endo, K; Matsuzaki, H; Sugiyama, S; Suzuki, Y; Tomiyoshi, K | 1 |
Ohana, I; Patton, JA; Sandler, MP; Weinfeld, Z | 1 |
Lamki, LM | 1 |
Benoit, T; Bury, T; Foidart-Willems, J; Hustinx, R; Jerusalem, G; Kaschten, BJ; Paulus, P; Rigo, P | 1 |
Bading, JR; Conti, PS; Grafton, ST; Hawley, K; Keppler, J; Lilien, DL | 1 |
Raylman, RR; Wahl, RL | 1 |
Ide, M; Shohtsu, A; Takagi, S; Yasuda, S | 1 |
Kotz, D | 1 |
Ichiya, Y | 1 |
Kusić, Z; Lacić, M; Maisey, MN | 1 |
Brock, CS; Meikle, SR; Price, P | 1 |
Deloar, HM; Fujiwara, T; Hayashi, Y; Itoh, M; Kanamaru, R; Miyake, M; Nakamura, T; Takahashi, H; Watabe, H; Yoshioka, T | 1 |
Bellemann, ME; Haberkorn, U | 1 |
Price, P | 1 |
Cronin, V; Galantowicz, P; Nabi, HA | 1 |
Hawkins, RA; Hoh, CK | 1 |
Fujibayashi, Y; Ishii, Y; Kato, H; Sadato, N; Waki, A; Yano, R; Yokoyama, A; Yonekura, Y | 1 |
Adhikari, JS; Dwarakanath, BS; Jain, V | 1 |
Fazio, F; Landoni, C; Valind, S; Wollmer, P | 1 |
Adhikari, JS; Bauch, T; Chandana, S; Dwarkanath, BS; Jain, V; Muller, WU; Streffer, C; Zolzer, F | 1 |
Ingram, DK; Lane, MA; Roth, GS | 1 |
Gopinath, PM; Jain, VK; Kalia, VK; Kucheria, K; Naqvi, S | 1 |
Jain, VK; Pohlit, W; Purohit, SC | 1 |
Minn, H; Paul, R | 1 |
Wilson, CB | 1 |
Dahlbom, M; Hawkins, RA; Hoffman, EJ; Hoh, CK; Phelps, ME; Rosenqvist, G; Schiepers, C | 1 |
Choi, Y; Hawkins, RA; Hoh, CK; Huang, SC; Messa, C; Phelps, ME | 1 |
Chen, B; Choi, Y; Dahlbom, M; Glaspy, J; Hawkins, RA; Hoh, C; Maddahi, J; Messa, C; Slamon, D; Tse, N | 1 |
Fukumura, T; Ichiya, Y; Jingu, K; Kuwabara, Y; Masuda, K; Otsuka, M; Tahara, T; Yoshikai, T | 1 |
Buchsbaum, DJ; Fisher, S; Grossman, HB; Hutchins, GD; Liebert, M; Wahl, RL | 1 |
Conti, PS; Strauss, LG | 1 |
Matsuzawa, T | 1 |
Fukuda, H; Matsuzawa, T; Tateno, Y | 1 |
Fukuda, H; Ido, T; Ito, M; Maeda, S; Matsuzawa, T; Takahashi, H; Wakui, A; Yamaguchi, K; Yang, PK | 1 |
Miraldi, F | 1 |
Johannsen, B | 1 |
Ahonen, A; Haaparanta, M; Johansson, R; Paul, R; Roeda, D; Sipilä, H; Solin, O | 1 |
Gridley, DS; Kettering, JD; Mantik, DW; Nutter, RL; Slater, JM | 1 |
Hatanaka, M | 1 |
34 review(s) available for deoxyglucose and Benign Neoplasms
Article | Year |
---|---|
Multifaceted entrancing role of glucose and its analogue, 2-deoxy-D-glucose in cancer cell proliferation, inflammation, and virus infection.
Topics: Adenosine Triphosphate; Cell Proliferation; Deoxyglucose; Glucose; Glycolysis; Humans; Inflammation; Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; TOR Serine-Threonine Kinases; Virus Diseases | 2022 |
Glycation and Antioxidants: Hand in the Glove of Antiglycation and Natural Antioxidants.
Topics: Antigens, Neoplasm; Antioxidants; Cardiovascular Diseases; Deoxyglucose; Diabetes Mellitus, Type 2; Gene Expression Regulation; Glycation End Products, Advanced; Glyoxal; Humans; Lactoylglutathione Lyase; Mitogen-Activated Protein Kinases; Neoplasms; NF-kappa B; Oxidative Stress; Plant Extracts; Polyphenols; Protein Carbonylation; Pyruvaldehyde; Signal Transduction | 2020 |
2-Deoxy-d-glucose exploits increased glucose metabolism in cancer and viral-infected cells: Relevance to its use in India against SARS-CoV-2.
Topics: COVID-19; Deoxyglucose; Glucose; Humans; India; Neoplasms; SARS-CoV-2 | 2021 |
Aberrant Uptake of a Fluorescent L-Glucose Analogue (fLG) into Tumor Cells Expressing Malignant Phenotypes.
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Deoxyglucose; Diagnostic Imaging; Filaggrin Proteins; Fluorescence; Fluorescent Dyes; Glucose; Humans; Neoplasms; Stereoisomerism | 2018 |
Manipulation of Glucose and Hydroperoxide Metabolism to Improve Radiation Response.
Topics: Animals; Auranofin; Buthionine Sulfoximine; Deoxyglucose; Glucose; Glycolysis; Humans; Hydrogen Peroxide; Neoplasms; Oxidation-Reduction; Oxidative Stress; Radiation-Sensitizing Agents | 2019 |
Energy restriction mimetic agents to target cancer cells: comparison between 2-deoxyglucose and thiazolidinediones.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Deoxyglucose; Energy Metabolism; Humans; Neoplasms; Thiazolidinediones | 2014 |
2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy.
Topics: Autophagy; Cell Death; Cell Line, Tumor; Deoxyglucose; Glucose; Humans; Molecular Targeted Therapy; Neoplasms; Oxidative Stress | 2014 |
Multifaceted effects of antimetabolite and anticancer drug, 2-deoxyglucose on eukaryotic cancer models budding and fission yeast.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Deoxyglucose; Drug Screening Assays, Antitumor; Energy Metabolism; Humans; Neoplasms; Schizosaccharomyces | 2017 |
Review: Deoxyglucose compounds labeled with isotopes different from 18-fuoride: is there a future in clinical practice?
Topics: Animals; Deoxyglucose; Diagnostic Imaging; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Mice; Neoplasm Transplantation; Neoplasms; Pentetic Acid; Positron-Emission Tomography; Radioisotopes; Rhenium; Technetium; Tomography, Emission-Computed, Single-Photon | 2008 |
From delocalized lipophilic cations to hypoxia: blocking tumor cell mitochondrial function leads to therapeutic gain with glycolytic inhibitors.
Topics: Anthracyclines; Antineoplastic Agents; Cations; Cell Hypoxia; Deoxyglucose; Glycolysis; Humans; Hypoxia; Mitochondria; Neoplasms; Reference Values; Rhodamine 123 | 2009 |
Targeting glucose metabolism with 2-deoxy-D-glucose for improving cancer therapy.
Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Deoxyglucose; Glucose; Humans; Neoplasms | 2009 |
Cytotoxicity, radiosensitization, and chemosensitization of tumor cells by 2-deoxy-D-glucose in vitro.
Topics: Animals; Antineoplastic Agents; Deoxyglucose; Humans; In Vitro Techniques; Neoplasms; Radiation Tolerance; Radiation-Sensitizing Agents; Radiotherapy | 2009 |
Protection of normal cells and tissues during radio- and chemosensitization of tumors by 2-deoxy-D-glucose.
Topics: Animals; Deoxyglucose; Humans; Neoplasms; Radiation Tolerance; Radiation-Sensitizing Agents | 2009 |
Differential toxic mechanisms of 2-deoxy-D-glucose versus 2-fluorodeoxy-D-glucose in hypoxic and normoxic tumor cells.
Topics: Anaerobiosis; Cell Hypoxia; Deoxyglucose; Glycolysis; Humans; Models, Biological; Neoplasms; Oxygen Consumption | 2007 |
Nuclear oncology 1984.
Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Bleomycin; Brain Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glioma; Humans; Liver Neoplasms; Male; Melanoma; Melanoma-Specific Antigens; Middle Aged; Neoplasm Proteins; Neoplasms; Tomography, Emission-Computed | 1984 |
[Positron-emission tomography: role of 18F-fluorodeoxyglucose (18FDG) imaging in oncology].
Topics: Cell Transformation, Neoplastic; Deoxyglucose; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gamma Cameras; Humans; Lymphatic Metastasis; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Predictive Value of Tests; Tomography, Emission-Computed | 1995 |
Positron emission tomographic oncology.
Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasms; Tomography, Emission-Computed | 1994 |
Positron emission tomography in oncology.
Topics: Carbon Radioisotopes; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Methionine; Neoplasms; Tomography, Emission-Computed | 1994 |
Use of positron emission tomography in oncology.
Topics: Brain Neoplasms; Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasms; Tomography, Emission-Computed | 1993 |
Can positron emission tomography (PET) be used to detect subclinical response to cancer therapy? The EC PET Oncology Concerted Action and the EORTC PET Study Group.
Topics: Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Deoxyglucose; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Humans; Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 1995 |
[Cancer diagnosis with positron emission tomography (PET)].
Topics: Carbon Radioisotopes; Clinical Trials as Topic; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Methionine; Neoplasms; Tomography, Emission-Computed | 1996 |
Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients.
Topics: Artifacts; Deoxyglucose; False Positive Reactions; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 1996 |
Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.
Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasms; Tomography, Emission-Computed | 1996 |
PET and [18F]-FDG in oncology: a clinical update.
Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasms; Tomography, Emission-Computed | 1996 |
[Diagnosis of cancers by FDG-PET].
Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Neoplasms; Prognosis; Tomography, Emission-Computed | 1997 |
Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?
Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Medical Oncology; Neoplasms; Tomography, Emission-Computed | 1997 |
[Positron emission tomography].
Topics: Animals; Blood Glucose; Brain Diseases; Deoxyglucose; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Neoplasms; Pharmacokinetics; Receptors, Neurotransmitter; Tomography, Emission-Computed | 1997 |
Caloric restriction in primates and relevance to humans.
Topics: Aging; Animals; Biomarkers; Blood Glucose; Body Temperature; Cardiovascular Diseases; Deoxyglucose; Diabetes Mellitus; Diet, Reducing; Drug Evaluation, Preclinical; Energy Intake; Energy Metabolism; Food Deprivation; Garcinia; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipids; Longevity; Macaca mulatta; Medicine, Ayurvedic; Metformin; Neoplasms; Phytotherapy; Plant Preparations; Primates; Rats; Rats, Inbred F344; Saimiri; Saponins; Triterpenes | 2001 |
PET scanning in oncology.
Topics: Deoxyglucose; Fluorodeoxyglucose F18; Humans; Methionine; Neoplasms; Tomography, Emission-Computed | 1992 |
The applications of PET in clinical oncology.
Topics: Brain Neoplasms; Colorectal Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasms; Tomography, Emission-Computed | 1991 |
[Positron emitters for the study of tumor metabolism].
Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Humans; Neoplasms; Tomography, Emission-Computed | 1989 |
[Potential use of positron-emission tomography in clinical oncology].
Topics: Carbon Radioisotopes; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fucose; Humans; Methionine; Neoplasms; Tomography, Emission-Computed | 1988 |
Potential of NMR and PET for determining tumor metabolism.
Topics: Brain Neoplasms; Cerebrovascular Circulation; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Spectroscopy; Neoplasms; Oxygen Consumption; Tomography, Emission-Computed | 1986 |
Transport of sugars in tumor cell membranes.
Topics: Animals; Antigens, Viral; Avian Sarcoma Viruses; Biological Transport; Carbohydrate Metabolism; Carbon Radioisotopes; Cell Line; Cell Membrane; Cell Transformation, Neoplastic; Cricetinae; Cyclic AMP; Cycloheximide; Cytochalasins; Deoxyglucose; Galactose; Glucosamine; Glucose; Hexosephosphates; Isomerism; Kidney; Kinetics; Leukemia Virus, Murine; Mannose; Methylglucosides; Models, Biological; Neoplasms; Puromycin; Temperature; Time Factors | 1974 |
5 trial(s) available for deoxyglucose and Benign Neoplasms
Article | Year |
---|---|
A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Glucose; Deoxyglucose; Docetaxel; Electrocardiography; Female; Humans; Male; Middle Aged; Neoplasms; Taxoids | 2013 |
Standardized uptake values of FDG: body surface area correction is preferable to body weight correction.
Topics: Body Surface Area; Body Weight; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Neoplasms; Tomography, Emission-Computed | 1994 |
[Cancer detection with whole-body FDG PET images without attenuation correction].
Topics: Adult; Aged; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 1996 |
[Tumor diagnosis using 18F-FDG SPECT].
Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Neoplasms; Tomography, Emission-Computed, Single-Photon | 1996 |
Performance study of a miniature gamma ray scintillation vivo probe for tumor localization.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Citrates; Deoxyglucose; Endoscopes; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium; Gallium Radioisotopes; Gamma Cameras; Humans; Lung Neoplasms; Lymphatic Metastasis; Lymphoma; Male; Middle Aged; Neoplasms; Phantoms, Imaging; Tomography, Emission-Computed | 1997 |
114 other study(ies) available for deoxyglucose and Benign Neoplasms
Article | Year |
---|---|
A non-catalytic scaffolding activity of hexokinase 2 contributes to EMT and metastasis.
Topics: A Kinase Anchor Proteins; A549 Cells; Animals; Carcinogenesis; Cell Line, Tumor; CHO Cells; Cricetulus; Cyclic AMP-Dependent Protein Kinase RIalpha Subunit; Deoxyglucose; Epithelial-Mesenchymal Transition; Female; Glucose; Glycogen Synthase Kinase 3 beta; Glycosylation; HCT116 Cells; HEK293 Cells; Hexokinase; Humans; Mice; Mice, Inbred BALB C; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Metastasis; Neoplasms; NF-E2-Related Factor 2; Phosphorylation; Rats; Snail Family Transcription Factors | 2022 |
A Comprehensive Biological and Synthetic Perspective on 2-Deoxy-d-Glucose (2-DG), A Sweet Molecule with Therapeutic and Diagnostic Potentials.
Topics: Adenosine Triphosphate; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Deoxyglucose; Epilepsy; Glycolysis; Humans; Isotope Labeling; Mitochondria; Neoplasms; Positron-Emission Tomography; SARS-CoV-2; Structure-Activity Relationship; Virus Replication | 2022 |
DNA Aptamer Beacon Probe (ABP) for Monitoring of Adenosine Triphosphate Level in SW480 Cancer Cells Treated with Glycolysis Inhibitor 2-Deoxyglucose.
Topics: Adenosine Triphosphate; Aptamers, Nucleotide; Biosensing Techniques; Deoxyglucose; Glycolysis; Guanosine Triphosphate; Neoplasms; Uridine Triphosphate | 2023 |
[
Topics: Bacterial Proteins; Carbon Isotopes; Deoxyglucose; Deuterium; Geobacillus stearothermophilus; Glucokinase; Hexokinase; Humans; Kinetics; Magnetic Resonance Spectroscopy; Neoplasms; Phosphorylation; Positron-Emission Tomography; Radiopharmaceuticals; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Stereoisomerism; Substrate Specificity | 2019 |
Co-delivery of 2-Deoxyglucose and a glutamine metabolism inhibitor V9302 via a prodrug micellar formulation for synergistic targeting of metabolism in cancer.
Topics: Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Drug Liberation; Drug Synergism; Female; Glucose; Glutamine; Humans; Mice, Inbred BALB C; Micelles; Neoplasms; Polyethylene Glycols; Prodrugs; Tissue Distribution | 2020 |
Blockade of
Topics: Deoxyglucose; Glycosylation; HMGB Proteins; Humans; Immunity, Cellular; Immunotherapy; Interleukin-2; K562 Cells; Neoplasm Proteins; Neoplasms; NK Cell Lectin-Like Receptor Subfamily K; T-Box Domain Proteins; T-Lymphocytes | 2020 |
Starvation and antimetabolic therapy promote cytokine release and recruitment of immune cells.
Topics: Activating Transcription Factor 4; Antimetabolites; Cell Death; Deoxyglucose; Epithelial Cells; Gene Expression Regulation; Glucose; Glutamine; HeLa Cells; Humans; Inflammation; Interleukin-6; Interleukin-8; Macrophages; Metformin; Neoplasms; NF-kappa B; Promoter Regions, Genetic; Starvation; Stress, Physiological | 2020 |
Association between a biomarker of glucose spikes, 1,5-anhydroglucitol, and cancer mortality.
Topics: Biomarkers; Blood Glucose; Deoxyglucose; Female; Glucose; Humans; Male; Neoplasms | 2020 |
Synthesis of a new deoxyglucose derivative modified near-infrared fluorescent probe for tumor diagnosis.
Topics: Animals; Cell Line, Tumor; Deoxyglucose; Fluorescent Dyes; Humans; Mice; Mice, Nude; Molecular Structure; Neoplasms | 2017 |
Targeting energy metabolism of cancer cells: Combined administration of NCL-240 and 2-DG.
Topics: Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Survival; Chlorophenols; Deoxyglucose; Drug Interactions; Energy Metabolism; Humans; Liposomes; Neoplasms; Triazoles | 2017 |
Aldo-keto reductases-mediated cytotoxicity of 2-deoxyglucose: A novel anticancer mechanism.
Topics: Aldehyde Reductase; Aldo-Keto Reductase Family 1 member B10; Animals; Antineoplastic Agents; Caco-2 Cells; Cell Line, Tumor; Cell Survival; Deoxyglucose; Glycolysis; HCT116 Cells; Hep G2 Cells; HT29 Cells; Humans; Male; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Neoplasms; Xenograft Model Antitumor Assays | 2018 |
A hypothetical method for controlling highly glycolytic cancers and metastases.
Topics: Blood Glucose; Cell Proliferation; Cerebrovascular Circulation; Deoxyglucose; Diet, Ketogenic; Glutamine; Glycolysis; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Models, Theoretical; Neoplasm Metastasis; Neoplasms | 2018 |
Enhancing the efficacy of glycolytic blockade in cancer cells
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Deoxyglucose; Drug Synergism; Female; Glycolysis; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Neoplasms; Rad51 Recombinase; Xenograft Model Antitumor Assays | 2019 |
MAGE cancer-testis antigens protect the mammalian germline under environmental stress.
Topics: Animals; Deoxyglucose; DNA Damage; Evolution, Molecular; Female; Gene Expression Regulation, Neoplastic; Germ Cells; Humans; Male; Melanoma-Specific Antigens; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Neoplasms; Spermatogenesis; Spermatogonia; Starvation; Stress, Physiological; Testis | 2019 |
A Warburg effect targeting vector designed to increase the uptake of compounds by cancer cells demonstrates glucose and hypoxia dependent uptake.
Topics: 4-Chloro-7-nitrobenzofurazan; Cell Hypoxia; Cell Line, Tumor; Deoxyglucose; Drug Delivery Systems; Glucose; Glucose Transport Proteins, Facilitative; Hexokinase; Humans; Models, Biological; Neoplasm Proteins; Neoplasms | 2019 |
Pyrvinium targets autophagy addiction to promote cancer cell death.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Autophagy; Cell Line; Deoxyglucose; Female; HCT116 Cells; HEK293 Cells; HeLa Cells; Humans; Mice; Mice, Inbred BALB C; Microtubule-Associated Proteins; Neoplasms; Pyrvinium Compounds; TOR Serine-Threonine Kinases; Transplantation, Heterologous; Zebrafish | 2013 |
Conversion of 2-deoxyglucose-induced growth inhibition to cell death in normoxic tumor cells.
Topics: Activating Transcription Factor 6; Animals; Antimetabolites, Antineoplastic; Biomarkers; Cell Death; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Deoxyglucose; eIF-2 Kinase; Glycosylation; Humans; Membrane Proteins; Mice; Neoplasms; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; RNA Interference; Unfolded Protein Response | 2013 |
The wonders of 2-deoxy-D-glucose.
Topics: Apoptosis; Autophagy; Deoxyglucose; Endoplasmic Reticulum Stress; Glycosylation; Humans; Hypoxia; Neoplasms; Virus Replication | 2014 |
AKT-mediated enhanced aerobic glycolysis causes acquired radioresistance by human tumor cells.
Topics: Aerobiosis; Cell Death; Chlorpropamide; Deoxyglucose; Glucose; Glucose Transporter Type 1; Glycolysis; HeLa Cells; Hep G2 Cells; Humans; Lactates; Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Radiation Tolerance; Reactive Oxygen Species | 2014 |
Antiproliferative effects of mitochondria-targeted cationic antioxidants and analogs: Role of mitochondrial bioenergetics and energy-sensing mechanism.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Antioxidants; Apoptosis; Cations; Cell Proliferation; Cyclic N-Oxides; Deoxyglucose; Dose-Response Relationship, Drug; Drug Synergism; Energy Metabolism; Glycolysis; Humans; MCF-7 Cells; Mitochondria; Neoplasms; Organophosphorus Compounds; Signal Transduction; Superoxide Dismutase; Superoxides; Time Factors | 2015 |
2-Deoxyglucose induces the expression of thioredoxin interacting protein (TXNIP) by increasing O-GlcNAcylation - Implications for targeting the Warburg effect in cancer cells.
Topics: Adenosine Triphosphate; Animals; Carrier Proteins; Cell Line, Tumor; Deoxyglucose; Dogs; Endoplasmic Reticulum Stress; Glycolysis; Glycosylation; HEK293 Cells; Hep G2 Cells; Humans; Madin Darby Canine Kidney Cells; Mice; Neoplasm Proteins; Neoplasms; Thioredoxins; Tumor Microenvironment | 2015 |
Glycolytic inhibitor 2-deoxyglucose simultaneously targets cancer and endothelial cells to suppress neuroblastoma growth in mice.
Topics: Actin Cytoskeleton; Actins; Animals; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Down-Regulation; Endothelial Cells; Glycolysis; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Mice, Inbred NOD; Mice, SCID; Neoplasms; Neuroblastoma; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-myc; Pseudopodia; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Xenograft Model Antitumor Assays | 2015 |
Identification of the determinants of 2-deoxyglucose sensitivity in cancer cells by shRNA library screening.
Topics: Antineoplastic Agents; Biological Transport, Active; Cell Line, Tumor; Coatomer Protein; Deoxyglucose; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Inhibitors; Gene Knockdown Techniques; Gene Library; Glycolysis; HCT116 Cells; HeLa Cells; Humans; Lipase; Lipid Metabolism; Neoplasms; Phenylurea Compounds; RNA, Small Interfering | 2015 |
Targeting cholesterol with β-cyclodextrin sensitizes cancer cells for apoptosis.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Aniline Compounds; Animals; Anticholesteremic Agents; Antimetabolites; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; beta-Cyclodextrins; Cell Line, Tumor; Crosses, Genetic; Deoxyglucose; Drug Synergism; Humans; Mice, Inbred NOD; Mice, SCID; Neoplasms; Specific Pathogen-Free Organisms; Sulfonamides; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |
DNA Glycation from 3-Deoxyglucosone Leads to the Formation of AGEs: Potential Role in Cancer Auto-antibodies.
Topics: Animals; Antibodies, Neoplasm; Autoantibodies; Case-Control Studies; Deoxyglucose; DNA, Neoplasm; Female; Glycation End Products, Advanced; Humans; Neoplasms; Rabbits | 2016 |
mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells.
Topics: Adenosine Triphosphate; Animals; Carcinoma; Cell Line, Tumor; Citric Acid Cycle; Combined Modality Therapy; Cytokines; Deoxyglucose; Drug Resistance, Neoplasm; Drug Synergism; Energy Metabolism; Everolimus; Female; Glucose-6-Phosphate Isomerase; Glutaminase; Glutamine; Glycolysis; Hep G2 Cells; Humans; Mechanistic Target of Rapamycin Complex 1; Metabolomics; Mice; Mice, Nude; Molecular Targeted Therapy; Multiprotein Complexes; Neoplasm Proteins; Neoplasms; Ovarian Neoplasms; Pentose Phosphate Pathway; Ribosomal Protein S6 Kinases, 70-kDa; RNA Interference; RNA, Small Interfering; TOR Serine-Threonine Kinases; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays | 2016 |
Combining 2-deoxy-D-glucose with fenofibrate leads to tumor cell death mediated by simultaneous induction of energy and ER stress.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Apoptosis; Cell Line, Tumor; Deoxyglucose; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; Female; Fenofibrate; Glycolysis; Heat-Shock Proteins; Humans; Hypolipidemic Agents; Mice, Nude; Neoplasms; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2016 |
2-Deoxy Glucose Modulates Expression and Biological Activity of VEGF in a SIRT-1 Dependent Mechanism.
Topics: Animals; Chick Embryo; Deoxyglucose; Gene Expression Regulation, Neoplastic; Glycolysis; HeLa Cells; Humans; Neoplasm Proteins; Neoplasms; Neovascularization, Pathologic; Sirtuin 1; Vascular Endothelial Growth Factor A | 2017 |
Suppression of gain-of-function mutant p53 with metabolic inhibitors reduces tumor growth in vivo.
Topics: A549 Cells; Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Deoxyglucose; Gene Expression Regulation, Neoplastic; Gene Knock-In Techniques; Humans; MAP Kinase Signaling System; Mice; Mutation; Neoplasm Metastasis; Neoplasms; Phenformin; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2016 |
Characterization and performance of a near-infrared 2-deoxyglucose optical imaging agent for mouse cancer models.
Topics: Animals; Cell Line, Tumor; Deoxyglucose; Diagnostic Imaging; Fluorescent Dyes; Fluoroimmunoassay; Humans; Indoles; Male; Mice; Mice, Nude; Microscopy, Fluorescence; Neoplasms; Spectroscopy, Near-Infrared; Xenograft Model Antitumor Assays | 2009 |
Synthesis and biological evaluation of a novel (99m)Tc nitrido radiopharmaceutical with deoxyglucose dithiocarbamate, showing tumor uptake.
Topics: Animals; Carbamates; Deoxyglucose; Isotope Labeling; Mice; Neoplasms; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution | 2009 |
The glycolytic inhibitor 2-deoxyglucose activates multiple prosurvival pathways through IGF1R.
Topics: Cell Line, Tumor; Cell Survival; Deoxyglucose; Glycolysis; Humans; Neoplasms; Phosphorylation; Receptor, IGF Type 1; Signal Transduction | 2009 |
Nucleocytoplasmic shuttling of hexokinase II in a cancer cell.
Topics: Active Transport, Cell Nucleus; Cell Nucleus; Cytoplasm; Deoxyglucose; Exportin 1 Protein; Fatty Acids, Unsaturated; Glucose; HeLa Cells; Hexokinase; Humans; Karyopherins; Neoplasms; Receptors, Cytoplasmic and Nuclear | 2010 |
Metabolic oxidative stress induced by a combination of 2-DG and 6-AN enhances radiation damage selectively in malignant cells via non-coordinated expression of antioxidant enzymes.
Topics: 6-Aminonicotinamide; Antioxidants; Catalase; Cell Line, Tumor; Deoxyglucose; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Humans; NADP; Neoplasms; Oxidative Stress; Radiation Tolerance; Superoxide Dismutase | 2010 |
A theoretical quantitative model for evolution of cancer chemotherapy resistance.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Deoxyglucose; Drug Resistance, Neoplasm; Humans; Maximum Tolerated Dose; Models, Theoretical; Neoplasms | 2010 |
A novel functional CT contrast agent for molecular imaging of cancer.
Topics: Biological Transport; Cell Line, Tumor; Contrast Media; Deoxyglucose; Gold; Humans; Metal Nanoparticles; Microscopy, Electron, Transmission; Neoplasms; X-Ray Microtomography | 2010 |
Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth.
Topics: AMP-Activated Protein Kinases; Animals; Antimetabolites; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxyglucose; Drug Synergism; Enzyme Activation; Humans; Hypoglycemic Agents; Male; Metformin; Mice; Mice, SCID; Neoplasms; Paclitaxel; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2011 |
Synthesis and characterization of a cell-permeable near-infrared fluorescent deoxyglucose analogue for cancer cell imaging.
Topics: Carbocyanines; Cell Line, Tumor; Cell Membrane Permeability; Deoxyglucose; Fluorescent Dyes; Glucosamine; Humans; Indoles; Molecular Structure; Neoplasms; Spectroscopy, Near-Infrared | 2011 |
A validated bioanalytical HPLC method for pharmacokinetic evaluation of 2-deoxyglucose in human plasma.
Topics: Antimetabolites, Antineoplastic; Chromatography, High Pressure Liquid; Deoxyglucose; Drug Stability; Fluorescent Dyes; Humans; Limit of Detection; Neoplasms; Reproducibility of Results; Sensitivity and Specificity | 2012 |
Efficient elimination of cancer cells by deoxyglucose-ABT-263/737 combination therapy.
Topics: Aniline Compounds; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biphenyl Compounds; Blotting, Western; Cell Line, Tumor; Cytochromes c; Deoxyglucose; Dose-Response Relationship, Drug; HeLa Cells; Hep G2 Cells; Humans; Male; Mice; Mice, Knockout; Mice, Nude; Mitochondria; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasms; Nitrophenols; Piperazines; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Survival Analysis; Tumor Burden; Xenograft Model Antitumor Assays | 2011 |
Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer models.
Topics: Animals; Deoxyglucose; Down-Regulation; Drug Evaluation, Preclinical; Energy Metabolism; Female; Humans; Hypoglycemic Agents; Metformin; Mice; Mice, Nude; Neoplasms; Signal Transduction; Treatment Outcome; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2011 |
Finding a Panacea among combination cancer therapies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Deoxyglucose; Drug Delivery Systems; Humans; Neoplasms | 2012 |
The combination of tephrosin with 2-deoxy-D-glucose enhances the cytotoxicity via accelerating ATP depletion and blunting autophagy in human cancer cells.
Topics: Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Cell Line, Tumor; Cell Survival; Deoxyglucose; Elongation Factor 2 Kinase; Enzyme Activation; Humans; Intracellular Space; Neoplasms; Rotenone | 2011 |
Synthesis and biodistribution of a new (99m) Tc-oxo complex with deoxyglucose dithiocarbamate for tumor imaging.
Topics: Animals; Carbamates; Cell Line, Tumor; Coordination Complexes; Deoxyglucose; Fluorodeoxyglucose F18; Mice; Mice, Nude; Neoplasms; Organotechnetium Compounds; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2012 |
A combination of 2-deoxy-D-glucose and 6-aminonicotinamide induces cell cycle arrest and apoptosis selectively in irradiated human malignant cells.
Topics: 6-Aminonicotinamide; Apoptosis; Blotting, Western; CDC2 Protein Kinase; Cell Cycle; Cell Cycle Checkpoints; Cell Division; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemoradiotherapy; Cyclin A; Cyclin B; Cyclin-Dependent Kinases; Deoxyglucose; Flow Cytometry; G2 Phase; Humans; Neoplasms; Reactive Oxygen Species | 2012 |
Optical molecular imaging approach for rapid assessment of response of individual cancer cells to chemotherapy.
Topics: 4-Chloro-7-nitrobenzofurazan; Analysis of Variance; Antineoplastic Agents; Apoptosis; Cell Survival; Choline; Cisplatin; Deoxyglucose; Fluorescent Dyes; HeLa Cells; Humans; Hydrazines; Microscopy, Fluorescence; Molecular Imaging; Neoplasms; Spheroids, Cellular | 2012 |
Targeted cancer therapy with a 2-deoxyglucose-based adriamycin complex.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Deoxyglucose; Doxorubicin; Glucose Transporter Type 1; Hep G2 Cells; Humans; MCF-7 Cells; Mice; Mice, Nude; Microscopy, Confocal; Models, Chemical; Molecular Structure; Neoplasms; Quercetin; Succinic Acid; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
The effect of 2-desoxy-D-glucose on glycolysis and respiration of tumor and normal tissues.
Topics: Cell Respiration; Deoxyglucose; Glucose; Glycolysis; Humans; Metabolism; Neoplasms | 1954 |
Inhibition of anaerobic glycolysis in Ehrlich ascites tumor cells by 2-deoxy-D-glucose.
Topics: Animals; Carcinoma, Ehrlich Tumor; Deoxyglucose; Glucose; Glycolysis; Humans; Neoplasms | 1958 |
Certain metabolic and pharmacologic effects in cancer patients given infusions of 2-deoxy-D-glucose.
Topics: Deoxyglucose; Encephalomyelitis; Glucose; Humans; Neoplasms | 1958 |
Inhibition of the crabtree effect in ascites carcinoma cells by 2-deoxy-D-glucose.
Topics: Ascites; Deoxyglucose; Glucose; Metabolism; Neoplasms | 1961 |
A comparison of the respiratory inhibitions induced by D-glucose and 2-deoxy-D-glucose in Ehrlich ascites carcinoma cells.
Topics: Animals; Ascites; Deoxyglucose; Glucose; Humans; Neoplasms | 1962 |
Oxidative DNA damage by hyperglycemia-related aldehydes and its marked enhancement by hydrogen peroxide.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aldehydes; Copper; Deoxyglucose; Deoxyguanosine; Diabetes Complications; DNA Damage; Drug Synergism; Glyceraldehyde; HL-60 Cells; Humans; Hydrogen Peroxide; Hyperglycemia; Neoplasms; Oxidation-Reduction | 2003 |
Hemopoietic cell transformation is associated with failure to downregulate glucose uptake during the G2/M phase of the cell cycle.
Topics: Animals; Cell Cycle; Cell Transformation, Neoplastic; Deoxyglucose; Down-Regulation; Energy Metabolism; G2 Phase; Glucose; Hematopoietic Stem Cells; Humans; Jurkat Cells; Mice; Mice, Inbred C57BL; Mitosis; Monosaccharide Transport Proteins; Neoplasms; S Phase; Up-Regulation | 2004 |
2-Deoxyglucose and radiosensitization: teaching an old DOG new tricks?
Topics: Deoxyglucose; Glucose; Glycolysis; Humans; Neoplasms; Radiation Tolerance | 2006 |
Comparison of 18F-fluoromethylcholine and 2-deoxy-D-glucose in the distribution of tumor and inflammation.
Topics: Animals; Autoradiography; Brain; Choline; Deoxyglucose; Fluorine Radioisotopes; Inflammation; Lung; Male; Neoplasm Transplantation; Neoplasms; Radiopharmaceuticals; Rats; Tissue Distribution; Turpentine | 2006 |
A central role for neuronal adenosine 5'-monophosphate-activated protein kinase in cancer-induced anorexia.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Anorexia; Deoxyglucose; Drug Administration Routes; Hypothalamus; Male; Metformin; Multienzyme Complexes; Neoplasm Transplantation; Neoplasms; Neurons; Phosphorylation; Protein Serine-Threonine Kinases; Rats; Rats, Wistar; Ribonucleotides; Survival Analysis; Tumor Cells, Cultured | 2007 |
[The effect of oxygenation on the biological behaviour of tumours].
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Hypoxia; Cell Line, Tumor; Dacarbazine; Deoxyglucose; Glioblastoma; Glycolysis; Humans; Hyperbaric Oxygenation; Kidney Neoplasms; Neoplasms; Oncogene Proteins; Oncolytic Virotherapy; Temozolomide; Transplantation, Heterologous | 2007 |
Under normoxia, 2-deoxy-D-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation.
Topics: Adenosine Triphosphate; Aerobiosis; Anaerobiosis; Cell Death; Cell Line, Tumor; Cell Survival; Deoxyglucose; Fluorodeoxyglucose F18; Glycolysis; Glycosylation; Humans; Mannose; Models, Biological; Neoplasms; Oligosaccharides; Oxygen; Oxygen Consumption; Protein Folding; Transcription Factor CHOP; Up-Regulation | 2007 |
Energy metabolism transition in multi-cellular human tumor spheroids.
Topics: Adenosine Triphosphate; Animals; Cell Line, Tumor; Deoxyglucose; Energy Metabolism; Fluorescent Dyes; Glycolysis; Gossypol; Humans; Lactones; Neoplasms; Organometallic Compounds; Oxidative Phosphorylation; Oxygen; Rhodamine 123; Spheroids, Cellular | 2008 |
2-Deoxyglucose induces Akt phosphorylation via a mechanism independent of LKB1/AMP-activated protein kinase signaling activation or glycolysis inhibition.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Antimetabolites; Blotting, Western; Checkpoint Kinase 1; Deoxyglucose; ErbB Receptors; Fluorescent Antibody Technique; Forkhead Box Protein O3; Forkhead Transcription Factors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Glycolysis; Humans; Luciferases; Multienzyme Complexes; Neoplasms; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Signal Transduction; Tumor Cells, Cultured | 2008 |
Release of histamine from human leukocytes stimulated with the tumor-promoting phorbol diesters. I. Characterization of the response.
Topics: Antibodies, Anti-Idiotypic; Calcium; Colchicine; Cyclic AMP; Deoxyglucose; Histamine Release; Humans; Immunoglobulin E; Leukocytes; Neoplasms; Phorbol Esters; Phorbols; Tetradecanoylphorbol Acetate; Time Factors | 1981 |
Imaging of canine cancers with 18F-2-fluoro-2-deoxy-D-glucose (FDG) suggests further applications for cancer imaging in man.
Topics: Animals; Deoxy Sugars; Deoxyglucose; Dog Diseases; Dogs; Female; Fluorine; Fluorodeoxyglucose F18; Male; Mammary Glands, Animal; Neoplasms; Osteosarcoma; Radioisotopes; Radionuclide Imaging | 1984 |
[Experimental study for cancer diagnosis with 18FDG: differential diagnosis of inflammation from malignant tumor].
Topics: Animals; Deoxy Sugars; Deoxyglucose; Diagnosis, Differential; Fluorine; Fluorodeoxyglucose F18; Inflammation; Neoplasms; Rabbits; Radioisotopes; Radionuclide Imaging | 1983 |
Differential uptake of 2-fluoro-2-deoxy-D-glucose.
Topics: Animals; Cells, Cultured; Chick Embryo; Deoxy Sugars; Deoxyglucose; Fibroblasts; Fluorodeoxyglucose F18; Humans; Mice; Neoplasms | 1983 |
Positron imaging feasibility studies. II: Characteristics of 2-deoxyglucose uptake in rodent and canine neoplasms: concise communication.
Topics: Animals; Deoxy Sugars; Deoxyglucose; Dog Diseases; Dogs; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasms; Rats; Rats, Inbred BUF; Sarcoma, Experimental; Tomography, Emission-Computed | 1981 |
Optimization of cancer therapy: Part IV--Effects of 2-deoxy-D-glucose on radiation induced chromosomal damage in PHA-stimulated peripheral human leukocytes.
Topics: Adult; Chromosome Aberrations; Deoxy Sugars; Deoxyglucose; DNA Repair; Humans; In Vitro Techniques; Leukocytes; Male; Neoplasms; Phytohemagglutinins | 1982 |
SUV: standard uptake or silly useless value?
Topics: Blood Glucose; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasms; Reference Standards; Tissue Distribution; Tomography, Emission-Computed | 1995 |
Highlights of the annual meeting of the European Association of Nuclear Medicine, Düsseldorf 1994.
Topics: Bone and Bones; Brain; Deoxyglucose; Europe; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Infections; Joints; Neoplasms; Nuclear Medicine; Radioimmunodetection; Radiotherapy; Societies, Medical; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1995 |
[Performance of a multispect 2 gamma camera for imaging 511-keV gamma rays].
Topics: Deoxyglucose; Electrons; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Rays; Humans; Models, Structural; Neoplasms; Nitrilotriacetic Acid; Organometallic Compounds; Organophosphonates; Organophosphorus Compounds; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 1995 |
Potential role of FDG-PET imaging in understanding tumor-host interaction.
Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Models, Biological; Neoplasms; Tomography, Emission-Computed | 1995 |
FDG-SPECT: correlation with FDG-PET.
Topics: Adult; Aged; Brain; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1995 |
Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG): initial evaluation in oncology and comparison with FDG PET.
Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Models, Structural; Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1995 |
Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies.
Topics: Adolescent; Child; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Infant; Lymphoma; Neoplasms; Neuroblastoma; Sarcoma, Ewing; Tomography, Emission-Computed | 1995 |
Cancer or inflammation? A Holy Grail for nuclear medicine.
Topics: Citrates; Citric Acid; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Inflammation; Lymphoma; Neoplasms; Sarcoidosis; Sensitivity and Specificity; Tomography, Emission-Computed | 1994 |
Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.
Topics: Adrenal Gland Diseases; Adrenal Gland Neoplasms; Aged; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms; Tomography, Emission-Computed | 1995 |
FDG-PET for the evaluation of tumor viability after anticancer therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms; Radiotherapy, High-Energy; Tomography, Emission-Computed | 1994 |
Technology for FDG SPECT with a relatively inexpensive gamma camera. Work in progress.
Topics: Adult; Brain; Costs and Cost Analysis; Deoxyglucose; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Heart; Humans; Male; Middle Aged; Models, Structural; Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1994 |
"Anatometabolic" tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity.
Topics: Adult; Algorithms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1993 |
FDG-PET in oncology: there's more to it than looking at pictures.
Topics: Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Neoplasms; Tomography, Emission-Computed | 1993 |
FDG accumulation in tumor tissue.
Topics: Cell Division; Deoxyglucose; Flow Cytometry; Fluorodeoxyglucose F18; Humans; Neoplasms; Tomography, Emission-Computed | 1993 |
Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-D-glucose.
Topics: Adult; Aged; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms; Phantoms, Imaging; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
Enhanced FDG-PET tumor imaging with correlation-coefficient filtered influx-constant images.
Topics: Artifacts; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Male; Neoplasms; Time Factors; Tomography, Emission-Computed | 1996 |
[Use of positron-emission tomography in oncology].
Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Neoplasms; Tomography, Emission-Computed | 1996 |
Standardized uptake values of fluorine-18 fluorodeoxyglucose: the value of different normalization procedures.
Topics: Algorithms; Body Constitution; Cohort Studies; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver; Lung; Male; Middle Aged; Neoplasms; Prospective Studies; Reference Values; Tissue Distribution; Tomography, Emission-Computed | 1996 |
1996 SNM annual meeting: medical problem solving.
Topics: Artifacts; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Colorectal Neoplasms; Contrast Media; Dementia; Deoxyglucose; Eye Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Genetic Therapy; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Neoplasms; Radioisotopes; Radiotherapy; Rhenium; Societies, Medical; Technetium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
Fluorodeoxyglucose (FDG) and tumour metabolism.
Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Neoplasms; Tomography, Emission-Computed | 1995 |
High-energy (511-keV) imaging with the scintillation camera.
Topics: Brain; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Heart; Humans; Neoplasms; Phantoms, Imaging; Technetium Tc 99m Sestamibi; Technology, Radiologic; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
Positron emission tomography in oncology. General acceptance of its role is overdue.
Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
Evaluation of ion-implanted-silicon detectors for use in intraoperative positron-sensitive probes.
Topics: Beta Particles; Deoxyglucose; Electrons; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Intraoperative Period; Neoplasms; Radiation Dosage; Radiometry; Radionuclide Imaging; Sensitivity and Specificity; Silicon | 1996 |
[Cancer screening with whole-body FDG PET].
Topics: Adult; Aged; Aged, 80 and over; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Middle Aged; Neoplasms; Prostatic Neoplasms; Tomography, Emission-Computed | 1996 |
The reinvention of PET.
Topics: Deoxyglucose; Fluorine Radioisotopes; Humans; Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1997 |
Positron emission tomography in oncology: the most sophisticated imaging technology.
Topics: Carbon Radioisotopes; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Methionine; Neoplasms; Tomography, Emission-Computed | 1997 |
Is there a future for PET in oncology?
Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Medical Oncology; Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |
Development of oncology protocol using fluorine-18-FDG: one center's experience.
Topics: Blood Glucose; Colonic Neoplasms; Deoxyglucose; Esophageal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphoma; Neoplasm Staging; Neoplasms; Patient Education as Topic; Practice Guidelines as Topic; Problem Solving; Quality Control; Quality of Health Care; Radiation Oncology; Radiology Information Systems; Radiopharmaceuticals; Rectal Neoplasms; Stomach Neoplasms; Tomography, Emission-Computed | 1997 |
PET FDG studies in oncology.
Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1994 |
Molecular nuclear medicine: the best kept secret in medicine.
Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasms; Nuclear Medicine; Radiopharmaceuticals; Societies, Medical; Tomography, Emission-Computed | 1997 |
The importance of glucose transport activity as the rate-limiting step of 2-deoxyglucose uptake in tumor cells in vitro.
Topics: 3-O-Methylglucose; Animals; Biological Transport; Cell Division; Cell Line; Deoxyglucose; Enzyme Activation; Glucose; Hexokinase; Humans; Monosaccharide Transport Proteins; Neoplasms; PC12 Cells; Rats; Tumor Cells, Cultured | 1998 |
Hematoporphyrin derivatives potentiate the radiosensitizing effects of 2-deoxy-D-glucose in cancer cells.
Topics: Animals; Antimetabolites; Carcinoma, Ehrlich Tumor; Carcinoma, Squamous Cell; Deoxyglucose; Dose-Response Relationship, Drug; Drug Synergism; Glucose; Glycolysis; Hematoporphyrins; Humans; Hydrogen-Ion Concentration; Mice; Micronucleus Tests; Neoplasms; Photosensitizing Agents; Radiation-Sensitizing Agents; Radiobiology; Spheroids, Cellular; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1999 |
[Rapid increase of the use of PET in cancer investigation--but Sweden lags behind].
Topics: Deoxyglucose; Fluorine Radioisotopes; Glucose; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Rectal Neoplasms; Sweden; Tomography, Emission-Computed; United States | 2000 |
Heterogeneity in 2-deoxy-D-glucose-induced modifications in energetics and radiation responses of human tumor cell lines.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Carcinoma, Squamous Cell; Deoxyglucose; DNA Damage; DNA Repair; Energy Metabolism; Glioma; Glucose; Humans; Lactic Acid; Melanoma; Micronucleus Tests; Neoplasms; Radiation Dosage; Radiobiology; Tumor Cells, Cultured | 2001 |
Optimization of cancer therapy: Part III--Effects of combining 2-deoxy-D-glucose treatment with gamma-irradiation on normal mice.
Topics: Animals; Chromosome Aberrations; Deoxy Sugars; Deoxyglucose; Gamma Rays; Male; Mice; Neoplasms | 1979 |
Influence of energy metabolism on the repair of x-ray damage in living cells. IV. Effects of 2-deoxy-D-glucose on the repair phenomena during fractionated irradiation of yeast.
Topics: Deoxy Sugars; Deoxyglucose; DNA Repair; Dose-Response Relationship, Radiation; Mutation; Neoplasms; Oxygen; Radiation Genetics; Radiation-Sensitizing Agents; Saccharomyces cerevisiae; X-Rays | 1975 |
Cancer treatment monitoring with fluorine-18 2-fluoro-2-deoxy-D-glucose and positron emission tomography: frustration or future.
Topics: Animals; Combined Modality Therapy; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasms; Tomography, Emission-Computed; Treatment Outcome | 1992 |
Whole-body positron emission tomography: Part I. Methods and performance characteristics.
Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Neoplasms; Time Factors; Tomography, Emission-Computed | 1992 |
Quantitating tumor glucose metabolism with FDG and PET.
Topics: Deoxyglucose; Fluorodeoxyglucose F18; Glycolysis; Humans; Neoplasms; Tomography, Emission-Computed | 1992 |
PET cancer evaluations with FDG.
Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glycolysis; Humans; Neoplasms; Tomography, Emission-Computed | 1991 |
Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography.
Topics: Adult; Aged; Carcinoma, Bronchogenic; Combined Modality Therapy; Deoxyglucose; Esophageal Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasms; Rectal Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed | 1991 |
18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomography.
Topics: Animals; Deoxyglucose; Feasibility Studies; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Tissue Distribution; Tomography, Emission-Computed | 1991 |
Current and future aspects of cancer diagnosis with PET.
Topics: Amino Acids; Carbon Radioisotopes; Deoxyglucose; Fluorine Radioisotopes; Humans; Neoplasms; Tomography, Emission-Computed | 1988 |
New approach to clinical evaluation of cancer chemotherapy using positron emission tomography with 18FDG (2-deoxy-2-[18F]fluoro-D-glucose).
Topics: Adenocarcinoma; Aged; Deoxy Sugars; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms; Radioisotopes; Stomach Neoplasms; Tomography, Emission-Computed | 1986 |
[Present status and trends in radiopharmacology].
Topics: Antibodies, Monoclonal; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Neoplasms; Radioisotopes; Radionuclide Imaging; Receptors, Dopamine; Technetium | 1987 |
Scintigraphy with [18F]2-fluoro-2-deoxy-D-glucose of cancer patients.
Topics: Adult; Aged; Deoxy Sugars; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Radioisotopes; Radionuclide Imaging | 1986 |
Mouse neoplasia and immunity: effects of radiation, hyperthermia, 2-deoxy-D-glucose, and Corynebacterium parvum.
Topics: Animals; Bacterial Vaccines; Body Temperature; Body Weight; Cell Line; Combined Modality Therapy; Deoxy Sugars; Deoxyglucose; Hot Temperature; Killer Cells, Natural; Lymphocyte Activation; Male; Mice; Mice, Inbred BALB C; Neoplasms; Organ Size; Phytohemagglutinins; Propionibacterium acnes; Spleen; Time Factors | 1985 |